Maravai LifeSciences Holdings, Inc. has grown revenue −27% a year over three years and −18% a year over five. Revenue growth, 3-year annual rate: −27% (Biotechnology median +17%). Revenue growth, 5-year rate: −18%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

MRVIMaravai LifeSciences Holdings, Inc.

Healthcare

$7.47+177% 1Y

$7.47

$2.6952 weeks$8.99

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+75.6 points), but revenue shrinking (−5% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −18% a year.

Margin direction+75.6 points operating

Trailing-twelve-month operating margin, -62.3% now against -137.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MRVI growing?

Maravai LifeSciences Holdings, Inc. has grown revenue −27% a year over three years and −18% a year over five.

−27%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −18%
Revenue growth, 5-year rate · −27% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›